U.S. Healthcare Services Stock News

NYSE:ORI
NYSE:ORIInsurance

Old Republic Fixed Income Deal And What It Means For Shareholders

Old Republic International (NYSE:ORI) has completed a substantial fixed-income offering, issuing new callable, senior, unsecured notes. The transaction adds fresh debt capital to the balance sheet, with terms structured around future call dates and interest payments. This funding move is designed to influence the company’s financial flexibility and long term funding mix. For investors tracking NYSE:ORI, the deal comes with the stock at $39.32 and a mixed return profile. Shares are up 11.4%...
NasdaqGS:BHF
NasdaqGS:BHFInsurance

Did Brighthouse Financial’s (BHF) Steep Q1 Revenue Drop and Wider Loss Just Shift Its Investment Narrative?

Brighthouse Financial, Inc. has reported first-quarter 2026 results, with revenue of US$1,527 million versus US$2,390 million a year earlier and a net loss of US$766 million, including a diluted loss per share from continuing operations of US$13.82, all reflecting a marked deterioration from the prior year period. These weaker results, marked by a very large year-over-year increase in net loss, raise fresh questions about the resilience of Brighthouse Financial’s earnings profile and...
NYSE:DAC
NYSE:DACShipping

Danaos Weighs Geopolitical Risks Against Fleet Growth And Valuation Potential

Danaos (NYSE:DAC) reports limited earnings impact from recent geopolitical disruptions, including the closure of the Strait of Hormuz, supported by long term charter coverage. The company is expanding its fleet in drybulk and LNG, adding Newcastlemax dry bulk carriers and 5,000 TEU containerships under new vessel orders. Contracted revenue backlog and additional energy sector investments point to a broader shift in how Danaos positions its shipping operations. For investors tracking...
NasdaqGS:DXCM
NasdaqGS:DXCMMedical Equipment

Is It Time To Revisit DexCom (DXCM) After Share Price Weakness And DCF Upside?

Wondering if DexCom at around US$61.63 is starting to look interesting again, or if the stock still carries too much downside risk for your portfolio? The share price has inched up about 1.7% over the past week and 0.7% over the past month, but is still down about 7.4% year to date and has declined about 27.9% over the past year. Recent headlines have focused on DexCom's role in continuous glucose monitoring and how that fits into broader healthcare technology trends, which can shape how...
NYSE:CALX
NYSE:CALXCommunications

Calix Bets On 50G PON And Wi Fi 7 For Future Growth

Calix expanded its AI-native Calix One platform to support standards-based 50G-PON. The company introduced an expanded Wi-Fi 7 appliance portfolio for service providers. The updates are aimed at residential, business, and multi-dwelling unit connectivity needs and federally funded broadband projects. Calix (NYSE:CALX) is pushing deeper into next generation fiber and wireless broadband with the 50G-PON extension to Calix One and a broader set of Wi-Fi 7 systems. The stock trades at $39.81,...
NYSE:GMED
NYSE:GMEDMedical Equipment

Globus Medical (GMED) Valuation Check After Share Price Drop And Solid Quarterly Results

Globus Medical (GMED) has fallen about 17% over the past week, even as its recent quarterly report showed higher sales and earnings and reaffirmed full year revenue guidance, putting the stock under closer investor scrutiny. See our latest analysis for Globus Medical. The recent 30 day share price return is down 18.94%, adding to a weaker 90 day share price return of 13% and pointing to fading short term momentum, even as the 1 year total shareholder return is 25.13%. If this kind of...
NasdaqGS:CALM
NasdaqGS:CALMFood

Assessing Cal-Maine Foods (CALM) Valuation After Mixed Returns And A 21.6% Undervaluation Signal

Recent price moves and what they might signal Cal-Maine Foods (CALM) has seen mixed share performance recently, with the stock down over the past year but higher over the past month, prompting investors to reassess how current pricing lines up with fundamentals. See our latest analysis for Cal-Maine Foods. At a share price of $76.88, Cal-Maine Foods has seen short-term share price returns edge higher in recent weeks while the 1-year total shareholder return is still down, although the 3-year...
NasdaqGS:ZVRA
NasdaqGS:ZVRAPharmaceuticals

Did One-Off-Boosted Q1 Profits Just Shift Zevra Therapeutics' (ZVRA) Investment Narrative?

Zevra Therapeutics reported first-quarter 2026 results showing sales of US$36.22 million and net income of US$37.89 million, a shift from a net loss a year earlier. The strong profit print was partly driven by unusual items and comes amid recent shareholder dilution, prompting closer scrutiny of the earnings quality. We’ll now explore how the earnings jump, aided by unusual items, affects Zevra Therapeutics’ existing investment narrative in rare disease therapies. We've uncovered the 12...
NYSE:DCH
NYSE:DCHAuto Components

Did Surging Q1 Sales but Ongoing Losses Just Shift Dauch's (DCH) Investment Narrative?

Dauch Corporation recently reported past first-quarter 2026 results, with sales rising to US$2,378.9 million from US$1,411.3 million a year earlier, alongside a net loss of US$100.3 million and a basic loss per share of US$0.52 from continuing operations. The company also modestly raised its 2026 sales guidance to a range of US$10.30–US$10.80 billion while still projecting a sizeable full-year net loss between US$335 million and US$180 million, highlighting a tension between revenue growth...
NYSE:NEM
NYSE:NEMMetals and Mining

Newmont Weighs Fourmile Deal And Solitario Stake For Future Gold Growth

Newmont (NYSE:NEM) is exploring a potential partnership with Barrick on the Fourmile gold discovery, often described as one of the century’s largest finds. The two companies are reported to be in early discussions on a development agreement that could shape the long term future of the Fourmile asset. Separately, Newmont has increased its ownership stake in Solitario Resources Corp., expanding its exposure to additional mining assets. Newmont, trading at $109.06, has a mixed recent track...
NYSE:GRND
NYSE:GRNDInteractive Media and Services

Is Grindr (GRND) Quietly Recasting Its Platform From Dating App To Travel And Community Ecosystem?

Earlier in May 2026, Grindr reported first-quarter 2026 results showing revenue of US$129.94 million and net income of US$26.75 million, raised its full-year 2026 revenue guidance to at least US$535 million, and brought back its Host or Travel original series to showcase LGBTQ+ travel and in-app engagement trends across major global cities. By pairing stronger guidance with content like Host or Travel that highlights real-world usage patterns and cross-border connections, Grindr is...
NasdaqGS:REAL
NasdaqGS:REALSpecialty Retail

Why RealReal (REAL) Is Down 11.7% After Lifting 2026 Guidance And Filing A Shelf Registration

In early May 2026, The RealReal reported first-quarter results showing year-over-year growth in sales to US$25.81 million and revenue to US$189.72 million, alongside positive net income of US$38.94 million, and also filed a universal shelf registration covering multiple security types. The company’s decision to raise full-year 2026 revenue guidance to US$770 million–US$784 million, while simultaneously putting a broad shelf registration in place, highlights management’s confidence in the...
NYSE:CNP
NYSE:CNPIntegrated Utilities

CenterPoint Equity Move Links New Capital To Storm Resilience Plans

CenterPoint Energy (NYSE:CNP) launched a new at the market equity distribution program for up to US$1b in common stock, replacing a prior arrangement. The company filed a new shelf registration statement covering a range of potential debt and equity securities. CenterPoint outlined ongoing investments in storm resilience, including a large hurricane response exercise and its Greater Houston Resiliency Initiative. CenterPoint Energy, a regulated utility serving electric and natural gas...
NasdaqGS:HWKN
NasdaqGS:HWKNChemicals

How Record Revenue and Acquisition Costs Will Impact Hawkins’ (HWKN) Water Treatment-Led Investment Story

Hawkins, Inc. reported past full-year 2026 results with sales rising to US$1,083.7 million while net income and diluted EPS eased slightly, and its board declared a quarterly dividend of US$0.19 per share payable in June 2026. The year’s record revenue was driven largely by strong expansion in the Water Treatment segment, boosted by six acquisitions that also increased interest and acquisition-related costs. We’ll now examine how this revenue growth led by Water Treatment, alongside the...
NasdaqGS:FFIN
NasdaqGS:FFINBanks

Is It Time To Reassess First Financial Bankshares (FFIN) After Recent Share Price Weakness?

If you are wondering whether First Financial Bankshares at around US$31.10 still offers value, the next sections will focus squarely on what the current price implies. The stock has slipped about 3.6% over the last week, is roughly flat over the past month with a 0.5% gain, has added 3.6% year to date, but is down about 11.2% over 1 year and around 31.2% over 5 years. This provides important context before looking at any valuation metrics. Recent coverage has focused on how regional banks...
NYSE:LOMA
NYSE:LOMABasic Materials

Loma Negra (LOMA) Reports Stronger Margins and Cash Flow: Is Its Profitability Story Shifting Gears?

Loma Negra Compañía Industrial Argentina Sociedad Anónima recently reported first-quarter 2026 results, with sales of ARS 218,739 million and net income of ARS 41,004 million, alongside higher earnings per share from continuing operations versus a year earlier. An interesting takeaway is that management credited a rebound in March cement activity and stronger margins for offsetting earlier industry softness and improving cash flow. Next, we’ll explore how this margin improvement and...
NYSE:WST
NYSE:WSTLife Sciences

West Pharmaceutical Cyberattack Tests Operational Resilience And Investor Risk Assumptions

West Pharmaceutical Services (NYSE:WST) reported a material cybersecurity incident involving data exfiltration and system encryption. The attack triggered a temporary suspension of global operations while the company worked to contain the breach. The full operational and financial impact remains uncertain as investigations and system restoration continue. West Pharmaceutical Services steps into this cyber event after a period of strong share price performance, with the stock up 40.3% over...
NYSEAM:UMAC
NYSEAM:UMACElectronic

Unusual Machines (UMAC) Margin Pressure Persists As Loss Per Share Challenges Growth Narrative

Unusual Machines (UMAC) opened Q1 2026 with Q4 2025 total revenue of about US$4.9 million and a loss per share (basic EPS) of US$0.29, alongside a net loss excluding extra items of roughly US$10.6 million. Over the previous quarters, revenue has ranged from about US$2.0 million to US$4.9 million, while basic EPS has shifted between a small profit of US$0.05 and losses of roughly US$0.20 to US$2.70. This gives investors a clearer view of how top line growth compares with ongoing losses. For...
NasdaqGS:CSIQ
NasdaqGS:CSIQSemiconductor

Canadian Solar Resets Focus On U.S. Manufacturing And Margin Quality

Canadian Solar (NasdaqGS: CSIQ) has appointed Colin Parkin as CEO, with founder Shawn Qu shifting to Executive Chairman and CTO. The company is reorienting its business toward value driven growth and profitability instead of pure volume expansion. Canadian Solar has begun trial production at its new HJT solar cell factory in Indiana and expanded module capacity in Texas to build out its U.S. manufacturing base. For you as an investor, this marks a key moment for one of the largest solar and...
NYSE:PUMP
NYSE:PUMPEnergy Services

ProPetro Holding (PUMP) Is Up 11.3% After $1.1 Billion Convertible Note Deal Is Announced

In early May 2026, ProPetro Holding Corp. completed and announced Rule 144A offerings of US$600,000,000 zero-coupon senior unsecured convertible notes due November 15, 2031, alongside a further US$500,000,000 senior unsecured callable convertible notes issue. This sizeable convertible financing package reshapes ProPetro’s capital structure, introducing potential future equity dilution while bolstering the company’s financial flexibility for growth and fleet modernization. We’ll now examine...
NYSE:OGE
NYSE:OGEElectric Utilities

Is OGE Energy (OGE) Pricing Look Stretching After Recent Gains And DDM Signals

Wondering if OGE Energy at around US$46.27 is offering fair value or a potential bargain? This article walks you through what the current price might be telling you. The stock is up 7.9% year to date and 8.3% over the last year, although it has slipped 2.3% over the past week and 4.7% over the past month, which may have shifted how some investors see its risk and reward trade off. Recent coverage has focused on how utility stocks like OGE Energy fit into portfolios when investors are...
NYSEAM:REI
NYSEAM:REIOil and Gas

Ring Energy (REI) Is Down 15.5% After Discounted Equity Raise To Pay Down Debt - What's Changed

Earlier this week, Ring Energy, Inc. completed a US$60.00 million follow-on common stock offering at US$1.35 per share, issuing 44,444,445 shares primarily to repay borrowings under its senior secured revolving credit facility. This capital raise follows a first-quarter 2026 net loss of US$220.59 million and coincides with expanded responsibilities for CFO Sundip “Sonu” S. Johl as Principal Financial Officer, underscoring management’s focus on balance sheet repair and financial...
NYSE:KVUE
NYSE:KVUEPersonal Products

Is It Time To Reconsider Kenvue (KVUE) After A 26% One-Year Share Price Decline

If you are wondering whether Kenvue stock is starting to look interesting at today’s price, the key question is how that price compares with a fair value estimate. The shares last closed at US$17.11, with returns down 2.7% over the past week, down 1.1% over the past month, down 1.2% year to date, and down 26.0% over the past year. Recent coverage has focused on how investors are reassessing consumer staples stocks, which can shift attention to balance sheet strength, cash generation and...
NasdaqCM:UNCY
NasdaqCM:UNCYBiotechs

Assessing Unicycive Therapeutics (UNCY) Valuation As Q1 Loss Widens And FDA Decision On OLC Nears

Why Unicycive Therapeutics (UNCY) is Back on Investors’ Radar Unicycive Therapeutics (UNCY) has drawn fresh attention after reporting its first quarter 2026 results, showing a net loss of $12.82 million alongside ongoing FDA review of oxylanthanum carbonate with a June 29, 2026 PDUFA date. This combination of a wider quarterly loss, preparations for a possible oxylanthanum carbonate launch, and a defined regulatory decision date is shaping how investors are reassessing the stock’s risk and...